A carregar...

Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety.

Biosimilars are here, but there’s no clear pathway yet for their approval. Difficult realities about their effect on drug prices, innovation, and competition need to be faced.

Na minha lista:
Detalhes bibliográficos
Main Authors: BLACKSTONE, ERWIN A., FUHR, JOSEPH P.
Formato: Artigo
Idioma:Inglês
Publicado em: BioCommunications LLC 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3351893/
https://ncbi.nlm.nih.gov/pubmed/22606078
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!